quinuclidines has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, MSR; Clarke, J; Kayatekin, C; Park, H; Richards, AM; Sardi, SP; Shihabuddin, LS; Viel, C; Wang, B | 1 |
| Chen, CH; Chou, YC; Huang, WY; Ju, UH; Kao, CH; Lin, CL; Lin, CS; Lin, KT; Lin, TY; Liu, FC; Shen, CH; Yang, TY | 1 |
| Cheng, SH; Clarke, J; Dodge, JC; Makino, E; Marshall, J; Olszewski, MA; Park, H; Richards, AM; Sardi, SP; Shihabuddin, LS; Sidman, RL; Treleaven, CM; Viel, C; Wang, B | 1 |
| Krivoborodov, GG; Mazo, EB | 1 |
1 review(s) available for quinuclidines and Parkinson Disease
| Article | Year |
|---|---|
[Neurological aspect of the hyperactive urinary bladder syndrome].
Topics: Benzilates; Brain; Brain Diseases; Cerebrovascular Circulation; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Neurogenic | 2005 |
3 other study(ies) available for quinuclidines and Parkinson Disease
| Article | Year |
|---|---|
Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model.
Topics: Animals; Carbamates; Disease Models, Animal; Glucosylceramidase; Glucosylceramides; Glucosyltransferases; Hippocampus; Mice; Mice, Inbred C57BL; Mutation; Parkinson Disease; Quinuclidines; Synucleinopathies | 2021 |
Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Comorbidity; Female; Humans; Hydroxychloroquine; Immunosuppression Therapy; Incidence; Male; Methylprednisolone; Middle Aged; Muscarinic Agonists; National Health Programs; Parkinson Disease; Pilocarpine; Quinuclidines; Retrospective Studies; Risk Factors; Sjogren's Syndrome; Taiwan; Thiophenes | 2019 |
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.
Topics: alpha-Synuclein; Animals; Carbamates; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Glucosyltransferases; Humans; Mice; Mutation; Parkinson Disease; Protein Aggregation, Pathological; Quinuclidines; tau Proteins; Ubiquitin | 2017 |